Literature DB >> 21798882

Detection of Trypanosoma cruzi in untreated chronic chagasic patients is improved by using three parasitological methods simultaneously.

Inés Zulantay1, Werner Apt, Claudio Valencia, Alberto Torres, Miguel Saavedra, Jorge Rodríguez, Lea Sandoval, Gabriela Martínez, Patricio Thieme, Eduardo Sepúlveda.   

Abstract

OBJECTIVES: This study compared three parasitological methods applied simultaneously in individuals with untreated chronic Chagas' disease in order to determine their individual and combined performances.
METHODS: From a total of 100 chronic chagasic patients from endemic areas of Chile, with informed consent, we extracted 2 mL of peripheral venous blood for PCR (PCR-B) and applied two xenodiagnosis (XD) boxes with seven uninfected Triatoma infestans nymphs each for microscopic examination and PCR of faecal samples of the triatomines fed on each patient (PCR-XD). The PCR-B and PCR-XD reactions were performed with oligonucleotides 121 and 122, which anneal to the four constant regions of the minicircles of Trypanosoma cruzi kinetoplasts. The 330 bp PCR product was analysed by electrophoresis in a 2% agarose gel and visualized by staining with ethidium bromide.
RESULTS: PCR-B detected T. cruzi in 58% of the cases, while PCR-XD proved to be more sensitive than XD (67% versus 14%, respectively) (P = 0.0001). There was no difference between the detection power of PCR-B and PCR-XD (P = 0.222). The percentage detected as positive was much greater when the three tests were considered (84%) (P = 0.00001).
CONCLUSIONS: The simultaneous application of more than one technique for the parasitological diagnosis of Chagas' disease in untreated individuals increases the possibility of detection of T. cruzi.

Entities:  

Mesh:

Year:  2011        PMID: 21798882     DOI: 10.1093/jac/dkr313

Source DB:  PubMed          Journal:  J Antimicrob Chemother        ISSN: 0305-7453            Impact factor:   5.790


  6 in total

1.  Detection of Trypanosoma cruzi infection in naturally infected dogs and cats using serological, parasitological and molecular methods.

Authors:  G F Enriquez; M V Cardinal; M M Orozco; A G Schijman; R E Gürtler
Journal:  Acta Trop       Date:  2013-03-13       Impact factor: 3.112

2.  Real-Time PCR in faecal samples of Triatoma infestans obtained by xenodiagnosis: proposal for an exogenous internal control.

Authors:  Nicolás Bravo; Catalina Muñoz; Nicolás Nazal; Miguel Saavedra; Gabriela Martínez; Eduardo Araya; Werner Apt; Inés Zulantay
Journal:  Parasit Vectors       Date:  2012-03-26       Impact factor: 3.876

3.  Development of an aptamer-based concentration method for the detection of Trypanosoma cruzi in blood.

Authors:  Rana Nagarkatti; Vaibhav Bist; Sirena Sun; Fernanda Fortes de Araujo; Hira L Nakhasi; Alain Debrabant
Journal:  PLoS One       Date:  2012-08-22       Impact factor: 3.240

4.  Trypanosoma cruzi strain TcI is associated with chronic Chagas disease in the Brazilian Amazon.

Authors:  Rosa Amélia Gonçalves Santana; Laylah Kelre Costa Magalhães; Laise Kelman Costa Magalhães; Suzane Ribeiro Prestes; Marcel Gonçalves Maciel; George Allan Villarouco da Silva; Wuelton Marcelo Monteiro; Felipe Rocha de Brito; Leila Inês de Aguiar Raposo Câmara Coelho; João Marcos Barbosa-Ferreira; Jorge Augusto Oliveira Guerra; Henrique Silveira; Maria das Graças Vale Barbosa
Journal:  Parasit Vectors       Date:  2014-06-11       Impact factor: 3.876

5.  Serum biomarkers predictive of cure in Chagas disease patients after nifurtimox treatment.

Authors:  Cynthia Santamaria; Eric Chatelain; Yves Jackson; Qianqian Miao; Brian J Ward; François Chappuis; Momar Ndao
Journal:  BMC Infect Dis       Date:  2014-06-03       Impact factor: 3.090

6.  Quantification by real-time PCR of Trypanosoma cruzi DNA in samples of Triatoma infestans used in xenodiagnosis of chronic Chagas disease patients.

Authors:  Miguel Saavedra; Inés Zulantay; Werner Apt; Juan Castillo; Eduardo Araya; Gabriela Martínez; Jorge Rodríguez
Journal:  Parasit Vectors       Date:  2016-07-04       Impact factor: 3.876

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.